Posimir
Product Images NDC 51715-660

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Posimir (NDC 51715-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Innocoll Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Posimir® is a bupivacaine solution with a concentration of 660mg/5mL (132mg/mL) for infiltration use only. It is packed in a 5mL single-dose vial, and the unused portion should be discarded. The drug contains bupivacaine, benzyl alcohol, and sucrose acefate isobutyrate. The solution color may range from light yellow to amber, but the color range does not affect potency. The recommended dosage is provided in the prescribing information, and the drug should be stored at 20-25°C (68-77°F) and protected from light. The drug is distributed by Innocoll Pharmaceuticals Limited, located in Athlone, Ireland.*

FDA Label Image

Principal Display Panel (5 mL Carton Label)

This seems to be a medical document containing information about a solution called "Posimir" which is used for infiltration. The recommended dosage information is provided and the unused portion needs to be discarded. The solution contains benzyl alcohol, sucrose-aceate isobutyrate, and bupivacaine. The range of color of the solution doesn't affect its potency. The document is produced by Innocoll Pharmaceuticals Limited.*

FDA Label Image

Structure Of Bupivacaine (Pos03 0001 01)

FDA Label Image

Figure 1 (Pos03 0001 02)

This appears to be a table showing pain intensity scores at different time points after surgery. The scores are presented as means with standard error values (+SE). The time intervals are measured in hours and range from 10 to 72.*

FDA Label Image

Figure 2 (Pos03 0001 03)

FDA Label Image

Figure 3 (Pos03 0001 04)

The text describes a graph or a chart showing the mean pain intensity score of a group of patients who were given either Placebo or Posimir, a drug, after surgery. The score is presented on the vertical axis, and time in hours after the surgery is shown on the horizontal axis. There is no additional information available in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.